z-logo
open-access-imgOpen Access
Pembrolizumab combined with FOLFOX4 chemotherapy for treatment of advanced hepatocellular carcinoma: Clinical efficacy and impact on serum levels of VEGF, TGF-β1, and bFGF
Author(s) -
Zhiyong Zheng,
Xiao-Le He
Publication year - 2022
Publication title -
shijie huaren xiaohua zazhi
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.114
H-Index - 16
eISSN - 2219-2859
pISSN - 1009-3079
DOI - 10.11569/wcjd.v30.i11.504
Subject(s) - hepatocellular carcinoma , medicine , pembrolizumab , vegf receptors , oncology , chemotherapy , gastroenterology , cancer , immunotherapy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom